TY - JOUR
T1 - Multiple biologic markers in the monitoring of treatment for patients with small cell carcinoma of the lung
T2 - The use of serial levels of plasma cea and serum carbohydrates
AU - Woo, Kwang B.
AU - Phillip Phd, T. Waalkes
AU - Abeloff, Martin D.
AU - Ettinger, David S.
AU - McNitt, Karen L.
AU - Gehrke, Charles W.
PY - 1981/10/1
Y1 - 1981/10/1
N2 - The monitoring utility of serial patterns of a single marker (carcinoembryonic antigen) level and multiple marker (three carbohydrates—fucose, mannose and galactose) levels in patients with small cell carcinoma of the lung was investigated using a quantitative approach. A serial multiple regression (SMR) model was formulated to assess the disease responses following the first to the tenth course of therapy and resulted in the multiple correlations ranging from 0.183 (NS)–0.706 (P < 0.005) for CEA, and 0.502 (P < 0.250)–0.760 (P < 0.025) for three carbohydrates, respectively. The appraisal of these markers utilizing the SMR model points out that: (1) the serial levels of CEA >5.0 ng/ml are significantly correlated with the disease course whereas the serial levels <5.0 ng/ml reflect the trend of variation in the disease course, but with less accuracy; and (2) the levels of three carbohydrates, any one elevated before and during therapy, are significantly correlated with the disease course.
AB - The monitoring utility of serial patterns of a single marker (carcinoembryonic antigen) level and multiple marker (three carbohydrates—fucose, mannose and galactose) levels in patients with small cell carcinoma of the lung was investigated using a quantitative approach. A serial multiple regression (SMR) model was formulated to assess the disease responses following the first to the tenth course of therapy and resulted in the multiple correlations ranging from 0.183 (NS)–0.706 (P < 0.005) for CEA, and 0.502 (P < 0.250)–0.760 (P < 0.025) for three carbohydrates, respectively. The appraisal of these markers utilizing the SMR model points out that: (1) the serial levels of CEA >5.0 ng/ml are significantly correlated with the disease course whereas the serial levels <5.0 ng/ml reflect the trend of variation in the disease course, but with less accuracy; and (2) the levels of three carbohydrates, any one elevated before and during therapy, are significantly correlated with the disease course.
UR - http://www.scopus.com/inward/record.url?scp=0019779085&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0019779085&partnerID=8YFLogxK
U2 - 10.1002/1097-0142(19811001)48:7<1633::AID-CNCR2820480727>3.0.CO;2-D
DO - 10.1002/1097-0142(19811001)48:7<1633::AID-CNCR2820480727>3.0.CO;2-D
M3 - Article
C2 - 6269720
AN - SCOPUS:0019779085
SN - 0008-543X
VL - 48
SP - 1633
EP - 1642
JO - Cancer
JF - Cancer
IS - 7
ER -